(44)Sc-PSMA-617 for radiotheragnostics in tandem with (177)Lu-PSMA-617—preclinical investigations in comparison with (68)Ga-PSMA-11 and (68)Ga-PSMA-617

BACKGROUND: The targeting of the prostate-specific membrane antigen (PSMA) is of particular interest for radiotheragnostic purposes of prostate cancer. Radiolabeled PSMA-617, a 1,4,7,10-tetraazacyclododecane-N,N′,N′′,N′′′-tetraacetic acid (DOTA)-functionalized PSMA ligand, revealed favorable kinetic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EJNMMI Res
Autors principals: Umbricht, Christoph A., Benešová, Martina, Schmid, Raffaella M., Türler, Andreas, Schibli, Roger, van der Meulen, Nicholas P., Müller, Cristina
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5247395/
https://ncbi.nlm.nih.gov/pubmed/28102507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-017-0257-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars